Because medical cannabis was only legalised in the UK in 2018, clinical investigation into its uses and benefits in the treatment of Parkinson’s disease are still ongoing, and although there have been promising findings, research in this area is still limited.
Currently, patients who have been unable to manage the symptoms of Parkinson’s using conventionally prescribed licensed treatments, may be considered eligible for cannabis-based Parkinson’s treatment plans with Releaf.
This is because real life evidence such as responses in patient surveys have displayed positive findings for the use of medical cannabis in the treatment of Parkinson’s symptoms, such as pain, tremors, poor sleep and low mood. These treatments may be able to aid those who have been unable to manage these symptoms with conventionally prescribed options.
While clinical investigations are still ongoing, it's important that medical cannabis Parkinson’s treatments are closely monitored by qualified healthcare professionals.
At Releaf, our team of specialist doctors can adapt or adjust the concentration and formulation of cannabis-based medicines, to best suit each individual patient, and can recommend dosing routines that won't disrupt day to day activities.